HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Spelman Selected Research

L Spelman Research Topics

Disease

3Psoriasis (Pustulosis Palmaris et Plantaris)
02/2022 - 12/2017
3Atopic Dermatitis (Atopic Eczema)
01/2021 - 01/2016
3Actinic Keratosis
11/2014 - 06/2003
2Inflammation (Inflammations)
01/2021 - 01/2016
1Eczema
01/2021
1Headache (Headaches)
01/2020
1Nasopharyngitis
01/2020
1Venous Thromboembolism
01/2020
1Disease Progression
01/2016
1Pain (Aches)
11/2014
1Eosinophilia-Myalgia Syndrome
06/2006
1Eosinophilic Fasciitis
06/2006
1Basal Cell Carcinoma (Rodent Ulcer)
04/2005

Drug/Important Bio-Agent (IBA)

3methyl 5-aminolevulinateIBA
05/2008 - 06/2003
21-phenyl-3,3-dimethyltriazene (PDT)IBA
11/2014 - 05/2008
1tildrakizumabIBA
02/2022
1CytokinesIBA
01/2021
1tralokinumabIBA
01/2021
1Interleukin-13IBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1baricitinibIBA
01/2020
1ixekizumabIBA
01/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020
1Janus Kinase 1IBA
01/2020
1ABP 501IBA
12/2017
1Adalimumab (Humira)FDA Link
12/2017
1Biosimilar PharmaceuticalsIBA
12/2017
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
01/2016
1crisaboroleIBA
01/2016
1KynurenineIBA
06/2006
1Tryptophan (L-Tryptophan)FDA Link
06/2006
1Quinolinic AcidIBA
06/2006

Therapy/Procedure

4Photochemotherapy (Photodynamic Therapy)
11/2014 - 06/2003
2Cryotherapy (Therapy, Cold)
05/2008 - 06/2003